0001562180-23-007189.txt : 20231003
0001562180-23-007189.hdr.sgml : 20231003
20231003193222
ACCESSION NUMBER: 0001562180-23-007189
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220203
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dearen Danny L.
CENTRAL INDEX KEY: 0001756438
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 231306145
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4/A
2022-02-03
2022-02-03
false
0001603756
Axonics, Inc.
AXNX
0001756438
Dearen Danny L.
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
President & CFO
false
Common Stock
2022-02-03
4
M
false
36919.00
0.00
A
57919.00
D
Common Stock
2022-02-03
4
S
false
17737.00
48.2103
D
40182.00
D
Common Stock
2022-02-03
4
S
false
947.00
49.0347
D
39235.00
D
This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s.
Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein.
This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Danny L. Dearen
2023-10-03